Caplight Directory>Companies>Karma Biotechnologies-preview>Karma-biotechnologies


Karma Biotechnologies

Karma Biotechnologies

Private
Torrance, CaliforniaHealthcare & Life Scienceshttps://www.karmabiotech.com

Last Round

Seed

Oct 25, 2023

Total Funding Raised

$500,000

Momentum Score

25 /100

Company Overview

Karma Biotechnologies is a biotechnology company specializing in immunotherapy solutions that promote antigen-specific immune tolerance in vivo.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vivo cell therapylipid nanoparticle technologyLNP technologyDNA/RNA co-deliverymacrophage reprogrammingsolid tumor treatmentLNP drug deliverynon-viral deliverygene therapymRNA therapyimmune cell reprogrammingCAR-Moncology therapeuticscold tumorsdrug delivery platformpharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Karma Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Karma Biotechnologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 25, 2023
GrantJan 10, 2022
SeedOct 14, 2015
View all Funding Rounds

Karma Biotechnologies Investors

Notable investors and investment history

InvestorRounds
Khosla VenturesSeed
Tech Coast AngelsSeed
IndieBioSeed
SOSVSeed
View all Investors

Karma Biotechnologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Karma Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Karma Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersTorrance, California
Employee Range2
Year Founded2017
Last FundingOct 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.